AGTC on NASDAQ

Applied Genetic Technologies Corporation

Logo: https://www.agtc.com/, Non-free logo, via Wikipedia4

Biotechnology company

The Applied Genetic Technologies Corporation was a publicly traded biotechnology company that is part of the NASDAQ Biotechnology Index. It was founded in 1999 and has its headquarters in Alachua, Florida.3 From Wikipedia, CC BY-SA 4.0

Price unavailable

Last updated Oct 16, 2026.

Overview

$325.0KRevenue, fiscal 20225
-$68.9MNet income, fiscal 20225
2001Founded1

Compare with BioAtla, Inhibikase Therapeutics, Inc. or Artiva Biotherapeutics, Inc., or pick any stock.

  • TickerAGTC on NASDAQ1
  • Industrybiotechnology1
  • HeadquartersAlachua1
  • Websitewww.agtc.com
  • Incorporated inDE6
  • Business address14193 Nw 119Th Terrace, Suite #10, Alachua, Fl 326156
  • Filer categoryNon-accelerated filer, Smaller reporting company6

See how the biggest companies compare on our leaderboards

The Applied Genetic Technologies Corporation was a publicly traded biotechnology company that is part of the NASDAQ Biotechnology Index. It was founded in 1999 and has its headquarters in Alachua, Florida. In late June 2019, the company announced the appointment of Global Clinical and Medical Affairs Veteran, Theresa G.H. Heah, M.D., M.B.A., to Join as Chief Medical Officer.3

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2022

-20361.5%Operating margin5
-21213.2%Net margin5
-35.0%Revenue growth, 20225
-233.9%Return on equity5
0.31×Debt to equity5
-$67.4MFree cash flow5

Where the money goes

Where each dollar of revenue went, fiscal 2022

  • Research and development95¢$49.5M
  • Interest5¢$2.7M

Out of $325.0K in revenue.5 The company lost money this year.

Financial statements

Revenue78910115$325.0K in 2022−86% since 2015
0$20.0M$40.0M$60.0M2015: $2.4M$2.4M20152016: $47.4M$47.4M2016+1912%2017: $39.5M$39.5M2017−17%2018: $24.2M$24.2M2018−39%2019: $41.7M$41.7M2019+72%2020: $2.5M$2.5M2020−94%2021: $500.0K$500.0K2021−80%2022: $325.0K$325.0K2022−35%
Operating income78910115-$66.2M in 2022+170% since 2015
-$80.0M-$60.0M-$40.0M-$20.0M0$20.0M2015: -$24.5M-$24.5M20152016: -$2.1M-$2.1M2016−91%2017: $1.9M$1.9M20172018: -$22.4M-$22.4M20182019: -$4.3M-$4.3M2019−81%2020: -$46.9M-$46.9M2020+979%2021: -$58.5M-$58.5M2021+25%2022: -$66.2M-$66.2M2022+13%
Net income78910115-$68.9M in 2022+184% since 2015
-$80.0M-$60.0M-$40.0M-$20.0M0$20.0M2015: -$24.3M-$24.3M20152016: -$1.4M-$1.4M2016−94%2017: $407.0K$407.0K20172018: -$21.3M-$21.3M20182019: -$2.0M-$2.0M2019−91%2020: -$45.9M-$45.9M2020+2188%2021: -$57.8M-$57.8M2021+26%2022: -$68.9M-$68.9M2022+19%
Fiscal year20152016201720182019202020212022
Revenue$2.4M7$47.4M8$39.5M8$24.2M9$41.7M10$2.5M11$500.0K5$325.0K5
Research and development$18.1M7$39.4M8$26.2M8$32.2M9$33.2M10$35.8M11$44.4M5$49.5M5
Operating income-$24.5M7-$2.1M8$1.9M8-$22.4M9-$4.3M10-$46.9M11-$58.5M5-$66.2M5
Interest$11.0K11$1.5M5$2.7M5
Income tax$2.4M8$72.0K9$76.0K10$83.0K11-$2.1M5$05
Net income-$24.3M7-$1.4M8$407.0K8-$21.3M9-$2.0M10-$45.9M11-$57.8M5-$68.9M5
Earnings per share-$1.507-$0.088$0.028-$1.189-$0.1110-$2.1711-$1.775-$1.535
Earnings per share (diluted)-$1.507-$0.088$0.028-$1.189-$0.1110-$2.1711-$1.775-$1.535

Compare Applied Genetic Technologies Corporation with another company

Timeline

  1. Mar 27, 2014Went public Listed on NASDAQ1
  2. 2001Founded Founded1

Recent filings

  1. Dec 1, 20228-K
  2. Dec 1, 20224 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
  3. Dec 1, 20224 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
  4. Dec 1, 20224 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
  5. Dec 1, 20224 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
  6. Dec 1, 20224 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
  7. Dec 1, 20224 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
  8. Dec 1, 20224 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
  9. Dec 1, 20224 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
  10. Dec 1, 20224 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
  11. Dec 1, 20224 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
  12. Dec 1, 20224 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
  13. Dec 1, 20224 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
  14. Dec 1, 20224 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
  15. Dec 1, 20224 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Every filing from the last three years, summarized. The full record is on SEC EDGAR.2

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14